ERBB2 and breast cancer: Metformin has been shown to suppress both the tyrosine kinase activity and the expression of the human epidermal growth factor receptor 2 (HER2) protein in in vitro models of HER2-overexpressing BC cells [17–20], in addition to prolonging survival in HER2-overexpressing transgenic BC mouse models [21].